| Application no. and date | 20701951.4 (espacenet) (Federated) (European Patent Register), 20200120 | | Patent/reg. no. and date | DK/EP 3911354, 20230719 | | Publication date | 20211124 | | Priority no. and date | EP 19305071, 20190118 | | EP pub. no. and date |
EP 3911354 20211124 | | Effective date | | | Applicant/owner | Institut Pasteur, 25-28, rue du Docteur Roux
75015 Paris, FR,
Institut National de la Santé et de la
Recherche Médicale (INSERM), 101 rue Tolbiac
75013 Paris, FR,
CENTRE NATIONAL DE LA RECHERCHE
SCIENTIFIQUE (CNRS), 3, rue Michel-Ange
75016 Paris, FR | | Applicant ref. no. | V465548DK00 | | Inventor | SAFIEDDINE, Saaid,
75012 Paris, FR,
PETIT, Christine,
75012 Paris, FR | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/16 (2006.01) , A61K 48/00 (2006.01) , A61P 27/16 (2006.01) , C07K 14/00 (2006.01) , C12N 15/86 (2006.01) | | Title | AVV-formidlet genterapi, der genskaber otoferlin-genet | | Int. application no. | EP2020051283 | | Int. publication no. | WO2020148458 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
